Home Featured Graymark Capital Pays $26.9MM for 128,000 SQFT Property Once Slated for Life Science Development in Emeryville
FeaturedFinanceINDUSTRY newsLeasingLife Science

Graymark Capital Pays $26.9MM for 128,000 SQFT Property Once Slated for Life Science Development in Emeryville

Share
Oakland skyline
Photo by Melpomenem on iStock
Share

The discounted acquisition of a once-promising biotech development site signals just how far Emeryville's life sciences market has cratered. A San Francisco real estate investor has scooped up a 128,000-square-foot Emeryville property at roughly half its previous sale price, in a transaction that crystallizes the collapse of the East Bay life sciences market that, just […]

Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Share

Partner Content

2026 Northern California CRE Rising Stars

NorCal rising stars 2026

Partner Content


Recent Posts

Related Articles

Swinerton Opens 30,000 SQFT Office at BXP’s 680 Folsom, Ending 25-Year Run at 260 Townsend in San Francisco

Swinerton has moved its San Francisco division out of 260 Townsend Street...

Investment-Grade Fresenius Kidney Care Clinic Spanning 26,000 SQFT Lists for $13.7MM in South Sacramento

An investment-grade dialysis operator's roughly $10 million bet on a former South...

McNellis: Choosin’ Texas?

Texas is booming, with new retail, data centers and people. But the...